ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0779

Sex Differences in the B Cell Compartment of Patients with Oligoarticular Juvenile Idiopathic Arthritis

Ki Pui Lam1, Claudia Harris1, Daniela Fernandez-Salinas1, Maryrose Hahn2, Maryam Ashoor3, Ahmad Bakhsh1, Carrie Bryant1, Siobhan Case1, Mia Chandler4, Joyce Chang5, Ezra Cohen1, Fatma Dedeoglu3, Olha Halyabar1, Jonathan Hausmann1, Melissa Hazen3, Daniel Ibanez1, Liyoung Kim1, Jeffrey Lo3, Mindy Lo3, Esra Meidan6, Megan Perron1, Helene Powers1, Mary Beth Son5, Holly Wobma7, Pui Lee8, Peter Nigrovic5, Laurie Ohlms9, Margaret Chang3, Maria Gutierrez-Arcelus3 and Lauren Henderson10, 1Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 2Boston Children's Hospital, Georgetown, MA, 3Boston Children's Hospital, boston, MA, 4Boston Children’s Hospital, Boston, MA, 5Boston Children's Hospital, Brookline, MA, 6Boston Children's Hospital, Somerville, MA, 7Division of Immunology, Boston Children's Hospital, Boston, MA, 8Boston Children's Hospital, Newton, MA, 9Department of Otolaryngology & Communication Enhancement, Boston Children’s Hospital, Harvard Medical School, Boston, MA, 10Boston Children's Hospital, Watertown, MA

Meeting: ACR Convergence 2024

Keywords: B-Lymphocyte, Juvenile idiopathic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: B Cell Biology & Targets in Autoimmune & Inflammatory Disease I

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: T peripheral helper (Tph) cells accumulate in the joints of children with ANA+ oligoarticular juvenile idiopathic arthritis (oligo JIA) and may provide pathogenic help to B cells. To understand Tph cell-B cell interactions in oligo JIA, we immunophenotyped and characterized the repertoire of synovial fluid (SF) B cells.

Methods: Peripheral blood (PB) and/or SF samples were obtained from children with oligo JIA (ILAR criteria) and adult/pediatric controls. To compare to other follicular lymphocytes, discard tonsils were collected from children undergoing tonsillectomy for indications such as sleep apnea. Flow cytometry was used to immunophenotype B cells and data were analyzed with FlowJo and OMIQ. Uniform manifold approximation and projections (UMAP) were created by downsampling to 2,000, live CD19+ B cells from each sample. Cluster analysis was performed with FlowSOM. Genomic DNA was extracted from sorted naïve, CD21lo, non-switched memory, and switched memory B cells and the immunoglobulin heavy chain was sequenced (Adaptive Biotechnologies). GraphPad Prism was used for statistical analysis.

 
 

Results: Table 1 summarizes study participants. We found immunophenotypic differences in SF B cells from male vs. female oligo JIA patients that were not observed in male vs. female PB and tonsil (Fig1A). When comparing SF from ANA+ oligo JIA patients, females had significantly more non-switched Bmem, switched Bmem, and plasmablast cells (Fig1B). There were no differences in B cell subsets of oligo JIA patients stratified by age of disease onset or ANA status alone. Next, an unsupervised clustering algorithm was used to identify 14 distinct population of B cells across the study groups. Six of these metaclusters were significantly and uniquely expanded in oligo JIA SF, including 5 clusters of CD21lo B cells of varying phenotype (Fig1C-D). In the SF of females with oligo JIA, there was enrichment of CD21lo B cells that expressed memory (CD27+) and age-associated B cell (ABC) (CD11chiTbet+CXCR3+) features (cluster 13) as well as plasmablasts (cluster 9) (Fig1E).
BCR repertoire analysis of females with oligo JIA showed that naïve, non-switched Bmem, and switched Bmem were less diverse and more clonal than their counterparts in the PB of controls and oligo JIA patients (Fig2A-B). Switched Bmem cells from oligo JIA SF had longer mean CDR3 lengths compared to oligo JIA and control PB, a feature associated with autoreactivity (Fig2C-D). Skewing of VH and JH genes was observed in Bmem cells from oligo JIA SF, including increased usage of the intrinsically autoreactive IgVH4-34 gene (Fig2E). Bmem cells from oligo JIA SF had BCRs with high frequencies of somatic hypermutation (SHM), comparable to Bmem cells in PB that are known to result from germinal center (GC) reactions (Fig2F).

Conclusion:  
Abnormalities in the SF B cell compartment were prominent in female vs. male oligo JIA patients, including enrichment of plasmablasts and CD21lo B cells with features of ABCs. The BCR repertoire of females with oligo JIA displayed evidence of autoreactivity and high rates of SHM indicative of T cell-dependent GC reactions. Thus, sex may play a role in oligo JIA B cells responses, which may explain the predilection of this disease to affect females.

Supporting image 1

Supporting image 2

Figure 1. Enrichment of memory B cells, plasmablasts and CD21lo B cells in the synovial fluid of females with oligo JIA. B cells were evaluated with flow cytometry. A-B) Percentage of naïve (CD27-IgD+), non-switched Bmem (CD27+IgD+), switched Bmem (CD27+IgD–), and plasmablast (CD27+CD38hi) cells among live, CD19+ B cells comparing A) males vs. females (statistical testing: non-parametric t-test) and B) the SF from ANA+ females with oligo JIA to all study groups (statistical testing: one-way ANOVA corrected for multiple comparisons. C) UMAPs generated from flow cytometry data showing 14 cell metaclusters in HC-PB (n=11), oligo JIA-PB (n=11), HC-Tonsil (n=11) and JIA-SF (n=11). D) Heatmap showing median expression of a given marker in each metacluster. Metaclusters highlighted in a blue box were significantly enriched in oligo JIA SF compared to HC-PB, JIA-PB, and HC-Tonsil (statistical testing: one-way ANOVA corrected for multiple comparisons). E) Subanalysis of the percentage of cells in each of the 14 metaclusters identified in panel C in male vs. female samples (n=4 in each group) (statistical analysis: one-way ANOVA with correction for multiple comparisons).
Summary data on bar graphs is mean ± standard error. P value, ns, >0.05; *, ≤ 0.05; **, ≤ 0.01; ***, ≤ 0.001; ****, ≤ 0.0001.
Oligo JIA, oligoarticular juvenile idiopathic arthritis; Bmem, memory B cells; SF, synovial fluid; ANA, antinuclear antibody; UMAP, uniform manifold approximation and projections; HC, healthy control; PB, peripheral blood.

Supporting image 3

Figure 2. Autoreactive features observed in the repertoire of synovial fluid B cells from females with oligo JIA. Repertoire analysis was conducted on sorted naïve B cells (CD3-CD19+CD27-IgD+CD21+), CD21lo (CD3-CD19+CD27-CD21lo), non-switched Bmem (CD3-CD19+CD27+IgD+) and switched Bmem (CD3-CD19+CD27+IgD-) from the PB of paediatric HC (n=3) and paired PB and SF from females with oligo JIA (n=5). A) Mean value of Shannon entropy, a measure of repertoire diversity, in each B cell subset. B) Mean productive clonality in each B cell subset. C) Histogram depicting the distribution of CDR3 nucleotide lengths in switched Bmem cells. D) Mean CDR3 length in switched Bmem cells. E) Mean frequency of usage of the IgVH4_34 gene in the B cell receptor of the given B cell population. F) Violin plots depicting z-scores for SHM for each B cell clone in a given B cells subset.
Statistical analysis for A, B, D: one-way ANOVA with correction for multiple comparisons with all groups compared to oligo JIA SF. Statistical analysis for E: two-way ANOVA corrected for multiple comparisons with all groups compared to oligo JIA SF.
Summary data on bar graphs is mean ± standard deviation (SD). P value, *, ≤ 0.05; **, ≤ 0.01; ***, ≤ 0.001; ****, ≤ 0.0001.
Oligo JIA, oligoarticular juvenile idiopathic arthritis; PB, peripheral blood; SF, synovial fluid; HC, healthy controls; HC, healthy controls; SF, synovial fluid; Bmem, memory B cells; CDR3, complementarity-determining region 3; SHM, somatic hypermutation.


Disclosures: K. Lam: None; C. Harris: None; D. Fernandez-Salinas: None; M. Hahn: None; M. Ashoor: None; A. Bakhsh: None; C. Bryant: None; S. Case: Foundation Medicine, 3, UpToDate, 3; M. Chandler: None; J. Chang: Century Therapeutics, 2; E. Cohen: None; F. Dedeoglu: UpToDate, 9; O. Halyabar: None; J. Hausmann: Novartis, 2; M. Hazen: None; D. Ibanez: None; L. Kim: None; J. Lo: None; M. Lo: None; E. Meidan: None; M. Perron: None; H. Powers: None; M. Son: None; H. Wobma: None; P. Lee: None; P. Nigrovic: American Academy of Pediatrics, 9, Bristol-Myers Squibb(BMS), 5, Century Therapeutics, 2, Edelweiss Immuno, 8, Fresh Tracks Therapeutics, 2, Merck/MSD, 2, Monte Rosa Therapeutics, 2, Novartis, 2, Pfizer, 2, 5, Qiagen, 2, Sobi, 2, UpToDate, 9; L. Ohlms: None; M. Chang: None; M. Gutierrez-Arcelus: None; L. Henderson: Adaptive Biotechnologies, 5, Bristol-Myers Squibb(BMS), 5, Pfizer, 1, Sobi, 2.

To cite this abstract in AMA style:

Lam K, Harris C, Fernandez-Salinas D, Hahn M, Ashoor M, Bakhsh A, Bryant C, Case S, Chandler M, Chang J, Cohen E, Dedeoglu F, Halyabar O, Hausmann J, Hazen M, Ibanez D, Kim L, Lo J, Lo M, Meidan E, Perron M, Powers H, Son M, Wobma H, Lee P, Nigrovic P, Ohlms L, Chang M, Gutierrez-Arcelus M, Henderson L. Sex Differences in the B Cell Compartment of Patients with Oligoarticular Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/sex-differences-in-the-b-cell-compartment-of-patients-with-oligoarticular-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-differences-in-the-b-cell-compartment-of-patients-with-oligoarticular-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology